Dissolved and financials
CVR: 43478060
DKK 0
Gross profit
Net result: DKK 500
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 2 September 2025
CVR · view overview
No headcount reported
Director role ended: Tore von Würden Petersen
CVR · 02/09/2025
View the full event history
Horizon Therapeutics Denmark ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company has been dissolved on 2 September 2025. The company was registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 500. Equity in the 2024 report amounted to DKK 40,947.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202401/01/2024 – 31/12/2024 | 0 | 500 | 46 t. | 41 t. | - |
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorNo. Horizon Therapeutics Denmark ApS is registered in the Danish CVR register with the status Dissolved and ceased on 2 September 2025.
The CVR number of Horizon Therapeutics Denmark ApS is 43478060.
In 2024, Horizon Therapeutics Denmark ApS reported a gross profit of DKK 0.
Horizon Therapeutics Denmark ApS was founded on 25 August 2022.
Horizon Therapeutics Denmark ApS was registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning (industry code 702000).
Horizon Therapeutics Denmark ApS was located at c/o CSC (DENMARK) ApS, Sundkrogsgade 21, 2100 København Ø.
As of September 2, 2025, Karin Louise Ulrika Järperud has left the board of directors of Horizon Therapeutics Denmark ApS.
As of September 2, 2025, Paraskevi Florou has left the board of directors of Horizon Therapeutics Denmark ApS.
As of September 2, 2025, Tore von Würden Petersen has stepped down as director of Horizon Therapeutics Denmark ApS.
As of September 2, 2025, Tore von Würden Petersen has stepped down as chairman of Horizon Therapeutics Denmark ApS.
As of September 2, 2025, Karin Louise Ulrika Järperud has stepped down as director of Horizon Therapeutics Denmark ApS.
As of September 2, 2025, Paraskevi Florou has stepped down as director of Horizon Therapeutics Denmark ApS.
Horizon Therapeutics Denmark ApS was dissolved on September 2, 2025.
Horizon Therapeutics Denmark ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK 500.
Horizon Therapeutics Denmark ApS has published its interim report for the period August 25, 2022 – December 31, 2023.
As of December 13, 2023, Karin Louise Ulrika Järperud has joined the board of directors of Horizon Therapeutics Denmark ApS.
As of December 13, 2023, Paraskevi Florou has joined the board of directors of Horizon Therapeutics Denmark ApS.
As of December 13, 2023, William David Gannon has left the board of directors of Horizon Therapeutics Denmark ApS.
As of December 13, 2023, David James Caraher has left the board of directors of Horizon Therapeutics Denmark ApS.
As of December 13, 2023, Tore von Würden Petersen is registered as director of Horizon Therapeutics Denmark ApS.
As of December 13, 2023, Tore von Würden Petersen is registered as chairman of Horizon Therapeutics Denmark ApS.
As of December 13, 2023, Karin Louise Ulrika Järperud is registered as director of Horizon Therapeutics Denmark ApS.
As of December 13, 2023, Paraskevi Florou is registered as director of Horizon Therapeutics Denmark ApS.
As of December 13, 2023, Patrick Paul McIlvenny has stepped down as adm. dir. of Horizon Therapeutics Denmark ApS.
As of December 13, 2023, Patrick Paul McIlvenny has stepped down as chairman of Horizon Therapeutics Denmark ApS.
As of August 25, 2022, William David Gannon has joined the board of directors of Horizon Therapeutics Denmark ApS.
As of August 25, 2022, David James Caraher has joined the board of directors of Horizon Therapeutics Denmark ApS.
As of August 25, 2022, Patrick Paul McIlvenny is registered as adm. dir. of Horizon Therapeutics Denmark ApS.
As of August 25, 2022, Patrick Paul McIlvenny is registered as chairman of Horizon Therapeutics Denmark ApS.
Horizon Therapeutics Denmark ApS was founded on August 25, 2022.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at drive forretning med digital markedsføring og strategi samt enhver i forbindelse hermed stående virksomhed.
Companies in the same industry and area
CVR 42928240
CVR 33975457
CVR 46120884
CVR 40185534
CVR 28123981
